Health

How has private equity hospital ownership impact the quality of labor & delivery care? – Healthcare Economist

• Health

How has private equity hospital ownership impact the quality of labor & delivery care? – Healthcare Economist

Ak February 18, 2026

The number of hospitals owned by private equity (PE) firms has increased...

Read More Read more about How has private equity hospital ownership impact the quality of labor & delivery care? – Healthcare Economist

Friday Links

• Health

Friday Links

Ak February 15, 2026

Expert Opinion: Will MFN lower US drug prices? Robots in Obstetric Care. What drives company decisions on...

Read More Read more about Friday Links

How is MFN likely to impact drug prices in the US and referenced countries? – Healthcare Economist

• Health

How is MFN likely to impact drug prices in the US and referenced countries? – Healthcare Economist

Ak February 12, 2026

This question is asked in a 2022 NBER working paper by Pierre Dubois, Ashwin Gandhi, and Shoshana...

Read More Read more about How is MFN likely to impact drug prices in the US and referenced countries? – Healthcare Economist

Links

• Health

Links

Ak February 9, 2026

Regulation and theory of adjacent probability. Alex Taborok on the Trump pharmaceutical plan. Double talk? IRA +...

Read More Read more about Links

Unveiling Parallels in Epidemiology, Clinical Pathways, and Therapeutic Strategies – Healthcare Economist

• Health

Unveiling Parallels in Epidemiology, Clinical Pathways, and Therapeutic Strategies – Healthcare Economist

Ak February 6, 2026

This is the title of the paper I published today Journal of...

Read More Read more about Unveiling Parallels in Epidemiology, Clinical Pathways, and Therapeutic Strategies – Healthcare Economist

How should you price new therapies when the standard of care is not cost effective? – Healthcare Economist

• Health

How should you price new therapies when the standard of care is not cost effective? – Healthcare Economist

Ak February 3, 2026

Suppose there is a very serious illness—let’s call it horror-With significant impact on patient morbidity and mortality....

Read More Read more about How should you price new therapies when the standard of care is not cost effective? – Healthcare Economist

What are FDA’s Guiding Principles of Good AI Practice in Drug Development? – Healthcare Economist

• Health

What are FDA’s Guiding Principles of Good AI Practice in Drug Development? – Healthcare Economist

Ak January 31, 2026

Here they are: Human-centered by design. The development and use of AI...

Read More Read more about What are FDA’s Guiding Principles of Good AI Practice in Drug Development? – Healthcare Economist

What is included in Trump’s “Great Healthcare Plan”? – Healthcare Economist

• Health

What is included in Trump’s “Great Healthcare Plan”? – Healthcare Economist

Ak January 28, 2026

President Trump unveiled “The Great Healthcare Plan” on January 15, 2026, calling on Congress to lower prescription...

Read More Read more about What is included in Trump’s “Great Healthcare Plan”? – Healthcare Economist

Tufts-CEVR HEOR Leaders Survey – Healthcare Economist

• Health

Tufts-CEVR HEOR Leaders Survey – Healthcare Economist

Ak January 25, 2026

How will HEOR leaders respond to recent policy changes? A survey from...

Read More Read more about Tufts-CEVR HEOR Leaders Survey – Healthcare Economist

What to watch for concerning drug pricing and market access in 2026 – Healthcare Economist

• Health

What to watch for concerning drug pricing and market access in 2026 – Healthcare Economist

Ak January 22, 2026

This is the subject of an evidence base article published today titled...

Read More Read more about What to watch for concerning drug pricing and market access in 2026 – Healthcare Economist